Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Contact Info
Unit 266, 267 & 268, Tower B1, Spaze Itech Park Sohna Road Gurugram, Haryana 122018 connect@complinity.com +91 8181 900 600
Follow Us

A Multi-Concept Theme for Digital Agencies and Startups

8181 900 600 Request a Demo Login
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
Mobile Logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Industry specific-Medical Central Ministry of Health & Family Welfare Clinical Establishments (Registration and Regulation) Act, 2010

The Health and Family Welfare Department, Government of Mizoram has issued a notification on exemption payment for treatment of rare diseases

07-Jun-2023 | No.A.12011/1/2015-PD/HFW/Vol-IV

The Health and Family Welfare Department, Government of Mizoram has issued a notification on exemption payment for treatment of rare diseases effective from 07.06.2023 with reference to Ministry of Health and Family Welfare D.O. letter No. 11037/91/2021-grants (RD) dt. 21.04.2023 and Notification for exemption of payment for Rare Diseases by Department of Revenue, Ministry of Finance. By virtue of the Notification, it has been stated that necessary actions are to be taken in publicizing and displaying the contents of above-mentioned notification on notice board of hospitals and Institutes and uploading in Department of Revenue site. Further, as per the notification dt. 21.04.2023, The National Policy for Rare Diseases, March 2021 aims at lowering the incidence and prevalence of rare diseases based on an integrated and comprehensive preventive strategy encompassing awareness generation, screening and counselling program whereas the Department of Revenue, Ministry of Finance, vide their Notification No. 02/2022-Customs dated 01.02.2022 had given exemption from payment of Basic Customs Duty for drugs or medicines used in the treatment of Rare Diseases when imported by Centres of Excellence (CoEs), specified in NPRD, 2021, or any person or institution, on recommendation of any Centre of Excellence listed in NPRD, 2021, certifying that the person (by name) for whom the drugs or medicines are imported, is suffering from a Rare Disease (to be specified by name) and requires the drugs or medicines for the treatment of the same. However, Prior to this In continuation of the above-mentioned Notification No.- 17/2023-Customs dt. 29.03.2023) has provided full exemption from payment of Basic Customs Duty (BCD) on all Drugs, Medicines or Food for Special Medical Purposes (FSMP), specified in List 38, imported for personal use for treatment of rare diseases identified and categorized under National Policy for Rare Diseases (NPRD), 2021.

Upgrade to paid version to access the Notification, Circular & Rules along with the checklist

Get Legal Updates in your email

Request a Demo

Recent Posts in Corporate Laws

Corporate Laws

NSE issues notification regarding Clearing Limited – Conducts Member Interface Testing of Two-Way Portability Across Clearing Corporations under SaaS Model

10-Aug-2026 | Circular Ref. No: 038/2026

NSE has issued notification regarding Clearing Limited – Conducts Member Interface Testing of Two-Way Portability Across Clearing Cor

Read More
Corporate Laws

NSE reiterate the circular issued by SEBI on Extension of timelines with respect to compliance of Digital Accessibility Circulars

31-Jul-2026 | 70/2026

NSE reiterated the circular issued by SEBI on Extension of timelines with respect to compliance of Digital Accessibility Circulars Through

Read More
Corporate Laws

BSE reiterate the circular issued by SEBI regarding Extension of timelines with respect to compliance of Digital Accessibility Circulars

31-Jul-2026 | 20260731-15

BSE reiterated the circular issued by SEBI regarding Extension of timelines with respect to compliance of Digital Accessibility Circulars T

Read More
Corporate Laws

NSE reiterate circular issued by SEBI regarding Operational guidelines on Handling of Client’s Unpaid Securities by Trading Members

31-Jul-2026 | Circular Ref. No: 41/2026

NSE reiterated circular issued by SEBI regarding Operational guidelines on Handling of Client’s Unpaid Securities by Trading Members

Read More

Recent Posts

Industry Specific- Pharma

Drugs (Prices Control) Amendment Order, 2026

30-Jun-2026 | S.O. 3516(E).

This notification further amends the Drugs (Prices Control) Order, 2013 by revising provisions relating to ceiling/retail prices, overchargi

Read More
Corporate Laws

NSE issues notification regarding Clearing Limited – Conducts Member Interface Testing of Two-Way Portability Across Clearing Corporations under SaaS Model

10-Aug-2026 | Circular Ref. No: 038/2026

NSE has issued notification regarding Clearing Limited – Conducts Member Interface Testing of Two-Way Portability Across Clearing Cor

Read More
Industry Specific - Food Laws

APEDA issues advisory on new Russian Gosudarstvennyy Standart (GOST) standards for dairy product exports

03-Aug-2026 | File no.: APEDA-AP/53/2026-AР

The Agricultural and Processed Food Products Export Development Authority (APEDA) has issued an advisory informing exporters of new and upda

Read More
Legal

Notification regarding Central Motor Vehicles (Twelfth Amendment) Rules, 2026

07-Aug-2026 | G.S.R. 712(E)

The amendment provides that, from 1 April 2027, all tippers and dumpers must be equipped with an electrically, electro-mechanically, hydraul

Read More
Request a Demo

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Complinity Logo Transparent

Complinity is a comprehensive cloud-based Compliance Management Software that helps track and monitor statutory and regulatory compliances.

Quick Links
  • Compliance Software
  • Regulatory Compliance Software
  • Statutory Compliance Software
  • Compliance Tracking Software
  • Legal Updates
Contact Info
Unit 266, 267 & 268, Tower B1
Spaze Itech Park, Sohna Road
Gurugram, Haryana 122018
connect@complinity.com
+91 8181 900 600

Request a Demo

© 2026 Complinity Technologies Private Limited. | Privacy Policy | Data Processing Addendum

Design & Developed By  Infinite IT Solutions

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Powered by EssentialPlugin

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Thank You for your interest in Complinity. Your CV has been forwarded to HR.
In case your profile is shortlisted, HR shall contact you.